{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:24:14Z","timestamp":1792265054139,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1136\/ijgc-2023-004465","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T09:51:04Z","timestamp":1684230664000},"page":"1057-1062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Definitive pelvic radiotherapy for patients with newly diagnosed stage IVB cervical cancer: a systematic review"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9395-0627","authenticated-orcid":false,"given":"David","family":"Viveros-Carre\u00f1o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Vieira-Serna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Fernando","family":"Grillo - Ardila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-4093","authenticated-orcid":false,"given":"Juliana","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia","family":"Mora-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0697-1815","authenticated-orcid":false,"given":"Anuja","family":"Jhingran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6370-8052","authenticated-orcid":false,"given":"Pedro T","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0093-0438","authenticated-orcid":false,"given":"Rene","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2023-004465_bb0010","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2023-004465_bb0015","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijgo.13865","article-title":"Cancer of the cervix uteri: 2021 update","volume":"155 Suppl 1","author":"Bhatla","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2023-004465_bb0020","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/IGC.0000000000001216","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer","volume":"28","author":"Cibula","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004465_bb0025","unstructured":"National Comprehensive Cancer Network (NCCN) . Cervical cancer (version 1.2023). National Comprehensive Cancer Network; Available: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cervical.pdf [Accessed 09 Jan 2023]."},{"key":"10.1136\/ijgc-2023-004465_bb0030","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.prro.2020.04.002","article-title":"Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline","volume":"10","author":"Chino","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1136\/ijgc-2023-004465_bb0035","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2023-004465_bb0040","first-page":"1033","article-title":"Radiation therapy for patients with bone metastasis from uterine cervical cancer: its role and optimal radiation regimen for palliative care","volume":"38","author":"Hata","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1136\/ijgc-2023-004465_bb0045","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ijrobp.2012.01.070","article-title":"Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases","volume":"84","author":"Kim","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2023-004465_bb0050","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"Br Med J"},{"key":"10.1136\/ijgc-2023-004465_bb0055","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11604-006-0082-6","article-title":"Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy","volume":"24","author":"Zighelboim","year":"2006","journal-title":"Radiat Med"},{"key":"10.1136\/ijgc-2023-004465_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13014-015-0373-0","article-title":"Tailored radiotherapeutic strategies for disseminated uterine cervical cancer patients","volume":"10","author":"Im","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1136\/ijgc-2023-004465_bb0065","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/ijgc-2020-001200","article-title":"Effect of addition of bevacizumab to chemoradiotherapy in newly diagnosed stage IVB cervical cancer: a single institution experience in Korea","volume":"30","author":"Youn","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-004465_bb0070","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.21873\/invivo.11655","article-title":"Radiation therapy for uterine cervical cancer with lung metastases including oligometastases","volume":"33","author":"Mukai","year":"2019","journal-title":"In Vivo"},{"key":"10.1136\/ijgc-2023-004465_bb0075","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2017.10.017","article-title":"Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer","volume":"148","author":"Ning","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004465_bb0080","article-title":"3D radiation therapy or intensity-modulated radiotherapy for recurrent and metastatic cervical cancer: the Shanghai Cancer Hospital experience","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1136\/ijgc-2023-004465_bb0085","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.21873\/invivo.12365","article-title":"Outcome of radiation therapy for stage IVB uterine cervical cancer with distant lymph nodes metastases; sequential irradiation for distant lymph nodes metastases","volume":"35","author":"Mukai","year":"2021","journal-title":"In Vivo"},{"key":"10.1136\/ijgc-2023-004465_bb0090","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ygyno.2022.04.013","article-title":"Local treatment improves survival in patients with stage IVB cervical cancer","volume":"165","author":"Xu","year":"2022","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004465_bb0095","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jamaoncol.2018.2677","article-title":"Association of definitive pelvic radiation therapy with survival among patients with newly diagnosed metastatic cervical cancer","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2023-004465_bb0100","first-page":"3471","article-title":"Prognostic factors and treatment outcome for patients with stage IVB cervical cancer","volume":"36","author":"Oishi","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1136\/ijgc-2023-004465_bb0105","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.21037\/tcr.2019.07.21","article-title":"Clinicopathologic characteristics and survival analysis in stage IVB cervical cancer with hematogenous metastasis","volume":"8","author":"Li","year":"2019","journal-title":"Transl Cancer Res"},{"key":"10.1136\/ijgc-2023-004465_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-019-1297-x","article-title":"Efficacy of radical doses of pelvic radiotherapy for primary tumor treatment in patients with newly diagnosed organ metastatic cervical cancer","volume":"14","author":"Yin","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1136\/ijgc-2023-004465_bb0115","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ygyno.2019.10.033","article-title":"Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: a novel treatment strategy","volume":"156","author":"Perkins","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004465_bb0120","doi-asserted-by":"crossref","first-page":"100963","DOI":"10.1016\/j.gore.2022.100963","article-title":"Definitive vs palliative pelvic radiation for patients with newly diagnosed stage IVB cervical cancer treated with bevacizumab-an exploratory study","volume":"40","author":"Wiley","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2023-004465_bb0125","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4143\/crt.2013.45.3.193","article-title":"Impact of chemoradiation on prognosis in stage IVB cervical cancer with distant lymphatic metastasis","volume":"45","author":"Kim","year":"2013","journal-title":"Cancer Res Treat"},{"key":"10.1136\/ijgc-2023-004465_bb0130","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1200\/JCO.2017.75.9985","article-title":"Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage IB2, IIA, or IIb squamous cervical cancer: a randomized controlled trial","volume":"36","author":"Gupta","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-004465_bb0135","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2023-004465_bb0140","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1200\/JCO.2009.21.8909","article-title":"Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study","volume":"27","author":"Monk","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-004465_bb0145","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(17)31607-0","article-title":"Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)","volume":"390","author":"Tewari","year":"2017","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2023-004465_bb0150","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2023-004465_bb0155","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-004465_bb0160","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-004465_bb0165","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002225.pub2","article-title":"Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix","author":"Green","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2023-004465_bb0170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2020.10.037","article-title":"Management of oligo-metastatic and oligo-recurrent cervical cancer: a pattern of care survey within the EMBRACE research network","volume":"155","author":"Chopra","year":"2021","journal-title":"Radiother Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24016311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24016311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2023-004465","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:39:54Z","timestamp":1753101594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24016311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1048891X24016311"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2023-004465","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definitive pelvic radiotherapy for patients with newly diagnosed stage IVB cervical cancer: a systematic review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2023-004465","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}